Welsh Cancer Intelligence and Surveillance Unit Uned Gwybodaeth a Gwyliadwriaeth Canser Cymru
|
|
- Harvey Barker
- 5 years ago
- Views:
Transcription
1 Cancer in Wales Incidence by stage at diagnosis 2011 to Latest available cancer incidence by stage at diagnosis official statistics for Wales for diagnosis years 2011 to 2015, by cancer type, age, sex, area deprivation, Wales and England, health board and local authority of residence Responsible statistician Rebecca Thomas Telephone Things you should know Introduction Melanoma and cancers of the uterus and breast have the highest proportion of early stage at diagnosis, whereas cancers of the lung, stomach, pancreas and liver have the lowest Trends in proportions of prostate and lung cancer early stage at diagnosis increased whilst unknown stage decreased There has been little change in breast cancer early stage at diagnosis and for all stages of bowel cancer 1 Cancer in Wales - Incidence by stage at diagnosis,
2 Older people tend to have higher proportions of unknown stage at diagnosis for most cancer types The proportion of people in each stage at diagnosis does not vary according to area deprivation for breast, prostate, bowel and lung cancer Trends in the proportion of lung cancer diagnoses at stage 1 increased across areas of all deprivation levels, and was largest in least deprived areas Lung cancer stage at diagnosis was similar in Wales and England apart from a higher level of stage 4 in England, and a higher level of unknown stage in Wales There is no significant variation between health boards in the proportion of stage 1 breast cancer at diagnosis Abertawe Bro Morgannwg University Health Board has the lowest proportion of people diagnosed with stage 1 lung cancer, less than half that in Cwm Taf 2 Cancer in Wales - Incidence by stage at diagnosis,
3 Things you should know First ever publication This statistical release is the first publication of its kind for Wales a national resident population-based profile of cancer incidence by the stage at diagnosis using cancer registry data. Stage at diagnosis refers to the size of a cancer and how far it has spread from where it originated at the time of diagnosis. Stage is summarised in cancer registries from 1 to 4; stage 1 indicates that the cancer is small and has not spread anywhere whereas stage 4 indicates the cancer has spread to at least one other body organ. Stage 1 and stage 2 usually refer to early stage. Stage 3 and stage 4 are referred to late stage at diagnosis. Unknown stage Cases of cancer recorded on the cancer registry may have an unknown stage for many reasons. Firstly, not all types of cancers can be staged (a minority). Out of stageable cancer sites then the stage at diagnosis may be unknown for some of the following reasons: Cancer registration system limitations Insufficient clinical data received to be able to derive cancer registry stage Exchange of data on cancer patients living in Wales but diagnosed or treated in England often did not include staging data until recently Patients might be too ill or turn down diagnostic tests to allow clinical staging The completeness of staging data captured by the Welsh Cancer Intelligence and Surveillance Unit has continued to improve beyond Further information about cancer registry data completeness and quality can be found here Registration processes have changed over the period with a new IT system which now includes more clinical data from hospitals in Wales, as well as England, and in addition to pathology data. Cancer teams in hospitals have also improved the reporting of stage. This is important because a high proportion of unknown stage at diagnosis can cause difficulties with interpretation of statistics along with difficulties comparing over time and between cancers. Statistical significance If a difference in the proportions of stage between populations is statistically significant, it means that difference is unlikely to have occurred due to chance alone, and that we can be more confident that we are observing a true difference. In this commentary we use the conventional arbitrary cut-off of less than 5% chance to mean statistically significant. Just because a difference is statistically significant doesn t necessarily mean that it is large or important that can depend on our judgement and other things. 3 Cancer in Wales - Incidence by stage at diagnosis,
4 Multiple testing has not been taken into account and so 1 in 20 tests will be statistically significant by chance alone. Breast cancer refers to female breast cancer only. Melanoma refers to melanoma of the skin only (i.e. not retina, for example). Some cancers cannot be staged using TNM (e.g. brain cancers) and some site specific staging classifications have not been captured at WCISU during this period (e.g. haematological cancers) and are not included in this report. Further information about the definitions can be found at 4 Cancer in Wales - Incidence by stage at diagnosis,
5 Introduction Early stage at diagnosis tends to be associated with an improved survival rate if there can be timely and equitable access to effective treatments. The key policy context for improving cancer control in Wales is the Welsh Government s refreshed Cancer Delivery Plan The Cancer Delivery Plan highlights how international studies have shown that Wales and other UK studies have historically had lower cancer survival than many other high income countries. One major contributor, amongst other factors, highlighted by some of these studies appears to be a tendency towards later stage at diagnosis. This first ever statistical release on national population-based cancer incidence by stage at diagnosis in Wales will directly inform the work of and provide a baseline for the NHS Wales Cancer Implementation Group s Detecting Cancer Early programme. 5 Cancer in Wales - Incidence by stage at diagnosis,
6 Melanoma and cancers of the uterus and breast have the highest proportion of early stage at diagnosis, whereas cancers of the lung, stomach, pancreas and liver have the lowest Figure 1: Proportion (%) of early and late stage at diagnosis for common cancer types for people resident in Wales, diagnosed in 2015 Early (1 and 2) stage Late (3 and 4) stage Unknown stage Melanoma Uterus Female breast Bladder Prostate Kidney Colon Bowel (Colorectal) Rectum Ovary Head & neck Oesophagus Lung Stomach Pancreas Liver Source: 's National Cancer Registry The distribution of stage at diagnosis varies considerably depending on the type of cancer. For many types early stage at diagnosis predominates, for example melanoma, uterus and breast. Bowel (colorectal) cancer has almost half of cases presenting at a late stage. Others, such as pancreas, stomach and lung cancer have predominantly late stages at diagnosis. Although liver cancer has the lowest proportion of early stage at diagnosis, it does not have the corresponding expected highest level of recorded late stage at diagnosis. This is almost certainly due to the high proportion of recorded stage as unknown. There are likely to be several reasons for this, described at the beginning of this commentary. The main reason is likely to be that most patients are late stage and may be too ill to have many staging tests or biopsies. 6 Cancer in Wales - Incidence by stage at diagnosis,
7 Trends in proportions of prostate and lung cancer early stage at diagnosis increased whilst unknown stage decreased There has been little change in breast cancer early stage at diagnosis and for all stages of bowel cancer Figure 2: Trends in proportion (%) of each stage at diagnosis for the commonest cancers from 2011 to 2015 Source: 's National Cancer Registry Here we describe the trends in the distribution of stage at diagnosis from 2011 to 2015 for the four commonest cancers in Wales. Although for breast cancer there was a small reduction in the proportion of stage 3 cases at diagnosis, this may have been in part due to an increase in the proportion of unknown stage. There was no significant change in the proportions of early stages (1 and 2), but the increase in unknown stage makes this hard to interpret. It is not yet clear why the proportion of unknown stage recorded in the cancer registry has increased. There was a large increase in the proportion of stage 2 prostate cancer cases, with smaller increases in the other stages, but with a large decrease in the 7 Cancer in Wales - Incidence by stage at diagnosis,
8 proportion of unknown stage cases. One main reason for the observed trends may be the redistribution of unknown stage to other known stages with improved stage reporting from cancer multi-disciplinary teams in hospitals. There was no significant change to the distribution of stage at diagnosis for bowel (colorectal) cancer between 2011 and The proportions of both stages 1 and 2 lung cancer increased between 2011 and The proportion of stage 1 cases almost doubled from 8.4% to 15.8%. At the same time, there was a significant decrease for unknown stage at diagnosis category. This may reflect in part a true stage shift of earlier lung cancer diagnosis in Wales as well as some redistribution from the unknown category. However, any changes due to decreasing the proportion of unknown stage would have probably only significantly increased later stages of diagnosis. 8 Cancer in Wales - Incidence by stage at diagnosis,
9 Older people tend to have higher proportions of unknown stage at diagnosis for most cancer types In 2015, there was a higher proportion of unknown stage at diagnosis for the older age group compared to the younger age group for most cancer types, apart from liver cancer. Women aged 75 years and over diagnosed with breast cancer had a significantly higher proportion of unknown stage at diagnosis (41.0%), compared to the two younger age groups (0-64 and years). The proportion of stage 1 breast cancer at diagnosis in women aged 75 years and over was also significantly lower (18.2%) than the younger age groups. Women with the highest proportion were aged years (44.6%). In all three age groups (0-64, 65-74, 75+ years), the proportion of men diagnosed with stage 1 prostate cancer was small, being smallest in the oldest age group (1.1%). Only a third of the oldest men were diagnosed with stage 2 disease, compared with over a half of men in the younger age groups. The proportion of men with prostate cancer of unknown stage at diagnosis was also the highest in the oldest men (33.5%). People diagnosed with bowel (colorectal) cancer aged 75 and over had a higher proportion with an unknown stage (21.8%) and a lower proportion with stage 1 disease (10.8%), than younger age groups. Younger people (0-64 years) with bowel (colorectal) cancer had a lower proportion with stage 2 at diagnosis (15.4%), along with a higher proportion of stage 4 disease (21.9%), compared to older age groups. The lower proportion of unknown cases may partly account for this finding. The 75 and over age group had a considerably higher proportion of unknown stage at diagnosis (19.4%) for lung cancer than each of the younger age groups. This is slightly offset by a higher proportion of stage 4 cases in the 0-64 year old age group. 9 Cancer in Wales - Incidence by stage at diagnosis,
10 The proportion of people in each stage at diagnosis does not vary according to area deprivation for the most common cancers (breast, prostate, bowel and lung cancer) Trends in the proportion of lung cancer diagnoses at stage 1 increased across areas of all deprivation levels, and was largest in least deprived areas Figure 3: Trends in stage at diagnosis (%) by area deprivation (quintiles) for female breast cancer in Wales, Source: 's National Cancer Registry In 2015, there was no significant difference in the proportion of female breast cancer cases in each stage at diagnosis between people living in areas of Wales with different levels of deprivation. The observed increase in the overall proportion of breast cancer cases of unknown stage is apparent for women who live in areas of all levels of deprivation. However, this increase is only statistically significant for the least, and next least deprived areas. In the least deprived areas, this change was associated with a small but significant decrease in the proportion of stage 3 cases. 10 Cancer in Wales - Incidence by stage at diagnosis,
11 Figure 4: Trends in stage at diagnosis (%) by area deprivation (quintiles) for prostate cancer in Wales, Source: 's National Cancer Registry In 2015, there was no significant difference in the proportion of prostate cancer cases in each stage at diagnosis between people living in areas of Wales with different levels of deprivation. The proportion of prostate cancer cases of unknown stage at diagnosis has decreased in areas of all levels of deprivation. This more than halved in the areas of most deprivation and those with the next least deprivation level. But it decreased by over two-thirds in men from the least deprived areas of Wales, where prostate cancer is more common. At the same time, the decrease in unknown stage proportions has possibly led to an increase in the proportions of late stage disease across areas of all levels of deprivation (significant increases of stage 4 disease in areas of middle to least deprivation, and stage 3 in middle deprived areas). But there were also large and statistically significant increases in the proportions of stage 2 prostate cancer across all levels of area deprivation. Finally, there was a small but statistically significant increase in the proportion of stage 1 prostate cancer only in the least deprived areas between 2011 and Cancer in Wales - Incidence by stage at diagnosis,
12 Figure 5: Trends in stage at diagnosis (%) by area deprivation (quintiles) for bowel (colorectal) cancer in Wales, Source: 's National Cancer Registry There has been no significant change to the distribution of stage at diagnosis for bowel cancer for all the levels of area disadvantage over the latest five year period. Figure 6: Trends in stage at diagnosis (%) by area deprivation (quintile) for lung cancer in Wales, Source: 's National Cancer Registry 12 Cancer in Wales - Incidence by stage at diagnosis,
13 There has been a large decrease in the proportion of unknown stage at diagnosis for people diagnosed with lung cancer across areas with all levels of deprivation. But during the same period there has not been a significant corresponding increase in the proportion of late stage disease for any level of deprivation. There has been an improvement for early stage disease across all areas, with increases in proportions of stage 2 lung cancer cases, and significant increases in stage 1 at diagnosis. Lung cancer is considerably more common in more deprived areas, and the increase in the proportion of stage 1 cases was the largest (10.0 percentage points) in people from the least deprived areas. 13 Cancer in Wales - Incidence by stage at diagnosis,
14 Lung cancer stage at diagnosis was similar in Wales and England apart from a higher level of stage 4 in England, and a higher level of unknown stage in Wales Figure 7: Stage at diagnosis (%) for breast cancer in Wales and England, 2015 Wales England stage stage stage stage unknown stage Source Wales: 's National Cancer Registry Source England: Although there is a wide gap between the proportion of female breast cancer cases at an early stage at diagnosis between Wales and England, the extent of unknown stage at diagnosis for female breast cancer in the cancer registry in Wales in 2015 makes meaningful comparison and interpretation difficult. 14 Cancer in Wales - Incidence by stage at diagnosis,
15 Figure 8: Stage at diagnosis (%) for bowel (colorectal) cancer in Wales and England, 2015 Wales England stage stage stage stage unknown stage Source Wales: 's National Cancer Registry Source England: Although in Wales there is a slightly higher proportion of stage 3 bowel cancer cases than England, there is a moderately higher proportion of later stage 4 disease in England. However, once more, comparison and interpretation is made difficult by the degree of unknown stage at diagnosis cases in 2015 in Wales. 15 Cancer in Wales - Incidence by stage at diagnosis,
16 Figure 9: Stage at diagnosis (%) for lung cancer in Wales and England, 2015 Wales England stage stage stage stage unknown stage Source Wales: 's National Cancer Registry Source England: The proportion of lung cancer cases at each stage at diagnosis was similar in Wales and England, apart from stage 4. This latest stage had almost seven percentage points more cases than in Wales. But, again, comparison and interpretation is made difficult by the proportion of unknown stage at diagnosis cases in the registry in Wales being higher than in England but only a seven percentage point difference. 16 Cancer in Wales - Incidence by stage at diagnosis,
17 There is no significant variation between health boards in the proportion of stage 1 breast cancer at diagnosis Abertawe Bro Morgannwg University Health Board has the lowest proportion of people diagnosed with stage 1 lung cancer, less than half that in Cwm Taf Figure 10: Proportion (%) of female breast cancer cases with each stage at diagnosis, by health board of residence, 2015, ranked by stage 1 proportion stage 1 stage 2 stage 3 stage 4 unknown stage Wales Aneurin Bevan UHB Hywel Dda UHB Cwm Taf UHB Betsi Cadwalader UHB Abertawe Bro Morgannwg UHB Cardiff and Vale UHB Powys THB Source: 's National Cancer Registry There is no significant variation between health boards in the proportion of stage 1 breast cancer at diagnosis. However, there is a significantly lower proportion of stage 2 cases in Betsi Cadwaladr compared to Wales as a whole. It is unclear whether this may be related to its relatively high proportion of unknown cases, which, in turn, may be related to historic cross-border data issues. Women diagnosed with breast cancer in the Aneurin Bevan area have a particularly low proportion of unknown stage cases. This may account for its relatively high but non-significant proportion of stage 3 cases. 17 Cancer in Wales - Incidence by stage at diagnosis,
18 Figure 11: Proportion (%) of bowel (colorectal) cancer cases with each stage at diagnosis, by health board of residence, 2015, ranked by stage 1 proportion stage 1 stage 2 stage 3 stage 4 unknown stage Wales Cardiff and Vale UHB Cwm Taf UHB Betsi Cadwalader UHB Aneurin Bevan UHB Abertawe Bro Morgannwg UHB Powys THB Hywel Dda UHB Source: 's National Cancer Registry Whilst there is variation in the proportion of unknown stage bowel cancer cases, no health board was statistically different to Wales as a whole. For late stage bowel cancer, no health board had a proportion of stage 4 disease different to Wales as a whole, but the proportion of stage 3 cases was significantly lower than Wales for Cardiff and Vale residents. 18 Cancer in Wales - Incidence by stage at diagnosis,
19 Figure 12: Proportion (%) of lung cancer cases with each stage at diagnosis, by health board of residence, 2015, ranked by stage 1 proportion stage 1 stage 2 stage 3 stage 4 unknown stage Wales Cwm Taf UHB Cardiff and Vale UHB Betsi Cadwalader UHB Powys THB Hywel Dda UHB Aneurin Bevan UHB Abertawe Bro Morgannwg UHB Source: 's National Cancer Registry The majority of people diagnosed with lung cancer presented at a late stage of disease in all Welsh health board areas, but there is still variation. Abertawe Bro Morgannwg residents had a proportion of unknown stage at diagnosis for lung cancer significantly higher than Wales as a whole. The reasons for this are unclear. Cardiff and Vale University Heath Board residents had the lowest proportion (statistically significant) of lung cancer unknown stage at diagnosis. Cwm Taf University Health Board stands out as having an unknown stage proportion similar to Wales as a whole, with a relatively small proportion of people with the latest stage 4 disease, along with the highest proportion with stage 1 lung cancer at diagnosis. Abertawe Bro Morgannwg University Health Board has the lowest proportion of people diagnosed at the earliest stage 1, less than half the proportion in Cwm Taf Public Health Wales NHS Trust. Material contained in the data provided to you may be reproduced under the terms of the Open Government Licence (OGL) provided it is done so accurately and is not used in a misleading context. Acknowledgement to Public Health Wales NHS Trust / WCISU to be clearly stated. 19 Cancer in Wales - Incidence by stage at diagnosis,
Cancer survival by stage at diagnosis in Wales,
Cancer survival by stage at diagnosis in Wales, 2011-2014 Welsh Cancer Intelligence and Surveillance Unit www.wcisu.wales.nhs.uk Latest available one-year net cancer survival by stage at diagnosis official
More informationWelsh Cancer Intelligence and Surveillance Unit, Public Health Wales
1 Project team Rebecca Thomas, Tamsin Long, Gareth Davies and Martin Holloway Reference group Ceri White, Helen Crowther, Joan Wilding, Karen Gully, Siôn Edwards, Richard Neal, Sean Young, John Lucy, Anne
More informationAneurin Bevan Health Board. Screening Programmes
Aneurin Bevan Health Board Screening Programmes 1 Introduction The purpose of this report is to inform Board Members of the screening services offered nationally by Screening Services, Public Health Wales
More informationKC53/61/65 Statistical Report Adroddiad Ystadegol 2012/13 Prepared by Cervical Screening Wales
KC53/61/65 Statistical Report Adroddiad Ystadegol 2012/13 Prepared by Cervical Screening Wales CERVICAL SCREENING WALES STATISTICAL REPORT CERVICAL SCREENING PROGRAMME, WALES: 2012/2013 For more information
More informationCancer Incidence and Mortality by Upper Super Output Area in Wales
Cancer Incidence and Mortality by Upper Super Output Area in Wales Welsh Cancer Intelligence and Surveillance Unit December 2009 Table of Contents 1 Introduction...... 1 2 Definitions of statistical terms.
More informationCommunity Pharmacy Influenza Vaccination A summary of the results of the national Community Pharmacy Seasonal Influenza Vaccination Service
Community Pharmacy Influenza Vaccination 2012-13 A summary of the results of the national Community Pharmacy Seasonal Influenza Vaccination Service Digital ISBN 978 0 7504 9511 0 Crown Copyright 2013 WG18824
More informationIn this edition: Newsletter Summer How Primary Care can help earlier diagnosis. Improving communication between Primary & Secondary Care
Newsletter Summer 2016 In this edition: How Primary Care can help earlier diagnosis Improving communication between Primary & Secondary Care A new approach to longer term care How primary care is adapting
More information8 Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 August 2013 (covering week )
8 Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 August 213 (covering week 33 213) Current level of activity: Low Trend: Stable compared to last week News: Update Middle East
More informationTuberculosis in Wales Annual Report 2014
Tuberculosis in Wales Annual Report 2014 Author: Communicable Disease Surveillance Centre Date: 20/03/2015 Version: 1 Status: Final Intended Audience: Health Purpose and Summary of Document: This report
More informationTuberculosis in Wales Annual Report 2015
Tuberculosis in Wales Annual Report 2015 Author: Communicable Disease Surveillance Centre Date: 10/03/2016 Version: 1 Status: Final Intended Audience: Health Purpose and Summary of Document: This annual
More informationPICTURE OF ORAL HEALTH 2012 DENTAL EPIDEMIOLOGICAL SURVEY OF 5 YEAR OLDS
PICTURE OF ORAL HEALTH 2012 DENTAL EPIDEMIOLOGICAL SURVEY OF 5 YEAR OLDS 2011-12 1 Contents Page Number Summary Introduction Preventable decay in Wales Preventable decay in Local Health Boards Preventable
More informationNHS WALES PRIMARY CARE PRESCRIBING ANALYSIS: TRAMADOL. April 2013
NHS WALES PRIMARY CARE PRESCRIBING ANALYSIS: TRAMADOL This report has been prepared by the Welsh Analytical Prescribing Support Unit (WAPSU), part of the All Wales Therapeutics and Toxicology Centre (AWTTC).
More informationStoryboard submission
Storyboard submission Follow the detailed instructions in this template for writing a description of your storyboard. Type your information in each section below and save this completed storyboard document
More informationSeasonal influenza in Wales /15
Seasonal influenza in Wales - 2014/15 Annual Report Page 1 of 43 Summary Taking into account information from all influenza surveillance indicators, the 2014/15 influenza season in Wales saw moderate levels
More informationDeath and dying in Wales
Death and dying in Wales An analysis of inconsistencies in access to specialist palliative care and hospital activity in the last year of life Marie Curie Cancer Care and the Bevan Foundation December
More informationCancer Annual Report. Cwm Taf University Health Board. September 2014
Cancer Annual Report Cwm Taf University Health Board September 2014 1 CONTENTS PAGE 1.0 Executive summary 3 2.0 Introduction 5 3.0 Cancer Incidence, Mortality and Survival in CTUHB 7 4.0 Our approach to
More informationTuberculosis in Wales Annual Report 2013
Tuberculosis in Wales Annual Report 2013 Author: Communicable Disease Surveillance Centre Date: 16/12/13 Version: 1 Status: Final Intended Audience: Health Purpose and Summary of Document: This report
More informationClostridium difficile (C. difficile) and Staphylococcus aureus bacteraemia (MRSA and MSSA) Bi-annual Report. Surveillance: Report:
Surveillance: Report: Clostridium difficile (C. difficile) and Staphylococcus aureus ( and ) Bi-annual Report Time period: 1 st April to 30 th September 2016 Health Board: Wales Content: Issued by: Pg
More informationPublic Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 st January 2015 (covering week )
The The Influenza B in certain countries8 Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 st January 215 (covering week 3 215) Current level of activity: Low Trend: Decreased
More informationThe Single Cancer Pathway
The Single Cancer Pathway Background and Case for Change Case for Change (1) Broadly patient experience of cancer services in Wales is good: 93% of patients rate their care as 7/10 or better (WPES) But
More informationTableau user guide for all Official Statistics
Health Intelligence Division, Public Health Wales Uned Deallusrwydd a Gwyliadwriaeth Canser Cymru Cyfadran Deallusrwydd Iechyd, Iechyd Cyhoeddus Cymru Tableau user guide for all Official Statistics There
More informationAneurin Bevan Health Board. Measles Emergency Response
Measles Emergency Response 1. Introduction The purpose of this paper is to inform the Board of the Measles Emergency Response measures and the work underway to try to prevent an epidemic of measles in
More information2014/15 ANNUAL REPORT OF THE POWYS HEART DISEASE DELIVERY PLAN. Director of Public Health. Director of Public Health
BOARD MEETING 21 OCTOBER 2015 AGENDA ITEM 2.8 2014/15 ANNUAL REPORT OF THE POWYS HEART DISEASE DELIVERY PLAN Report of Director of Public Health Paper prepared by Director of Public Health Principal Health
More informationTuberculosis in Wales Annual Report 2016
Tuberculosis in Wales Annual Report 2016 Author: Communicable Disease Surveillance Centre Date: 03/11/2016 Version: 1 Status: Final Intended Audience: Health Purpose and Summary of Document: This annual
More informationWales Primary Care COPD Audit
Wales Primary Care COPD Audit 2014-15 Next steps for improvement National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme 2016 The audit programme partnership Working in strategic partnership:
More informationUptake of pertussis and influenza vaccination in pregnant women in Wales
Vaccine Preventable Disease Programme Uptake of pertussis and influenza vaccination in pregnant women in Wales 2013-14 Authors: Anne McGowan, Richard Lewis, Richard Roberts, Simon Cottrell. Vaccine Preventable
More informationNational Prescribing Indicators Analysis of Prescribing Data to September 2015
National Prescribing Indicators 2016 Analysis of Prescribing Data to tember National Prescribing Indicators 2016. Analysis of Prescribing Data to tember EXECUTIVE SUMMARY The All Wales Medicines Strategy
More informationSeasonal influenza in Wales 2016/17
Much Seasonal influenza in Wales 2016/17 Annual Report Page 1 of 53 Summary The 2016/17 influenza season in Wales arrived and peaked earlier than the previous two seasons and reached moderate levels. Influenza
More informationA research briefing paper by Macmillan Cancer Support
A research briefing paper by Macmillan Cancer Support Introduction Key findings 3 People with cancer are surviving longer 4 Median survival time has seen dramatic improvement for some cancers 5 Median
More informationDon t let falls get you down
19 February 2013 Don t let falls get you down Dr Sarah J Jones, Consultant, Environmental Health Protection, Public Health Wales Insert name of presentation on Master Slide Structure Epidemiology Evidence
More informationInformation Services Division NHS National Services Scotland
Cancer in Scotland April 2017 First published in June 2004, revised with each National Statistics publication Next due for revision October 2017 Information Services Division NHS National Services Scotland
More informationInformation Services Division NHS National Services Scotland
Cancer in Scotland October 2012 First published in June 2004, revised with each National Statistics publication Next due for revision April 2013 Information Services Division NHS National Services Scotland
More informationNational COPD Audit Programme
National COPD Audit Programme Planning for every breath Primary Care Audit (Wales) 2015-17 Findings and quality improvement The audit programme partnership Working in strategic partnership: Supported by:
More informationInformation Services Division NHS National Services Scotland
Cancer in Scotland April 2013 First published in June 2004, revised with each National Statistics publication Next due for revision October 2013 Information Services Division NHS National Services Scotland
More informationCancer prevalence. Chapter 7
Chapter 7 Cancer prevalence Prevalence measures the number of people diagnosed with cancer who are still alive. This chapter presents current and historical statistics on cancer prevalence in Ontario.
More informationUK Complete Cancer Prevalence for 2013 Technical report
UK Complete Cancer Prevalence for 213 Technical report National Cancer Registration and Analysis Service and Macmillan Cancer Support in collaboration with the national cancer registries of Northern Ireland,
More informationDesigned to Smile. Beliefs and attitudes of the Community Dental Service. staff to the Designed to Smile Programme. Evaluation Stage 2 Part III
Designed to Smile Beliefs and attitudes of the Community Dental Service staff to the Designed to Smile Programme Evaluation Stage 2 Part III November 2015 H. Stanton and I.G.Chestnutt Dental Public Health
More informationNHS WALES PRIMARY CARE PRESCRIBING ANALYSIS FOR TRAMADOL DATA TO SEPTEMBER 2014
NHS WALES PRIMARY CARE PRESCRIBING ANALYSIS FOR TRAMADOL DATA TO SEPTEMBER 2014 March 2015 This report has been prepared by the Welsh Analytical Prescribing Support Unit (WAPSU), part of the All Wales
More informationHIGH BLOOD PRESSURE. How can we do better?
HIGH BLOOD PRESSURE How can we do better? Review date: February 2018 This publication includes practical guidance from GPs, nurses and pharmacists on how you can improve detection and management of high
More informationNational Cancer Registration and Analysis Service Short Report: Chemotherapy, Radiotherapy and Surgical Tumour Resections in England: (V2)
National Cancer Registration and Analysis Service Short Report: Chemotherapy, Radiotherapy and Surgical Tumour Resections in England: 13-14 (V2) Produced as part of the Cancer Research UK - Public Health
More informationLung Cancer 2013 Peer Review All Wales Report
Lung Cancer 2013 Peer Review All Wales Report This publication and other HIW information can be provided in alternative formats or languages on request. There will be a short delay as alternative languages
More informationImmunisations and screening
5.1 5.2 Newborn screening 5 85 Key messages Immunisation is one of the most effective and cost effective ways to protect children against serious infectious diseases. The recommended uptake of childhood
More informationEpidemiology in Texas 2006 Annual Report. Cancer
Epidemiology in Texas 2006 Annual Report Cancer Epidemiology in Texas 2006 Annual Report Page 94 Cancer Incidence and Mortality in Texas, 2000-2004 The Texas Department of State Health Services Texas Cancer
More informationSUBSTANCE MISUSE PROGRAMME. Drug deaths in Wales 2017
SUBSTANCE MISUSE PROGRAMME Drug deaths in Wales 2017 About Public Health Wales Public Health Wales exists to protect and improve health and wellbeing and reduce health inequalities for people in Wales.
More informationDownloaded from:
Rachet, B; Coleman, MP; Ellis, L; Shah, A; Cooper, N; Rasulo, D; Westlake, S (8) Cancer survival in the Primary Care Trusts of England, 1998-4. Technical Report. Office for National Statistics. Downloaded
More informationJournal of the Statistical and Social Inquiry Society of Ireland Volume XXXIX. D.W. Donnelly & A.T. Gavin
Journal of the Statistical and Social Inquiry Society of Ireland Volume XXXIX TRENDS AND PATTERNS IN CANCER MORTALITY IN NORTHERN IRELAND D.W. Donnelly & A.T. Gavin NI Cancer Registry, Queen s University
More informationNewborn Bloodspot Screening (NBS) Training for Health Visitors. December 2017
Newborn Bloodspot Screening (NBS) Training for Health Visitors www.newbornbloodspotscreening.wales.nhs.uk December 2017 Aims To enable you to gain a clear understanding of the following: Aim and rationale
More informationUnited Kingdom and Ireland Association of Cancer Registries (UKIACR) Performance Indicators 2017 report Published XX June 2017
United Kingdom and Ireland Association of Cancer Registries (UKIACR) Performance Indicators 2017 report Published XX June 2017 UKIACR Performance Indicators 2017 report 1 Contents Introduction... 3 Commentary
More informationBowel Cancer Profile for Oldham, Business Intelligence Service
Bowel Cancer Profile for Oldham, 2015 Business Intelligence Service December 2015 Overview of Report This report provides an assessment of a range of measures (prevalence, incidence, mortality, years of
More informationNational Cancer Statistics in Korea, 2014
National Cancer Statistics in Korea, 2014 2016. 12. 20. Korea Central Cancer Registry Cancer Incidence in Korea, 2014 National Cancer Incidence, 2014 Trends in Cancer Incidence by Sex and Year * Dark colored
More informationWales Cancer Patient Experience Survey Hywel Dda University Health Board. Published January 2014
Wales Cancer Patient Experience Survey 2013 Hywel Dda University Health Published January 2014 The Wales Cancer Patient Experience Survey was undertaken by Quality Health on behalf of the Welsh Government
More informationCancer Survival in Wales, Goroesi Cancr yng Nghymru,
Cancer Survival in Wales, 1989-1998 Goroesi Cancr yng Nghymru, 1989-1998 Welsh Cancer Intelligence & Surveillance Unit Uned Arolygiaeth a Gwybodaeth Cancr Cymru DIRECTOR S INTRODUCTION I am pleased to
More informationAnnual statement of progress Liver Disease Delivery Plan May 2017
Annual statement of progress Liver Disease Delivery Plan May 2017 Overview Liver disease is the third most common cause of premature death in the UK and the national liver disease health outcomes are worse
More informationCardiff and Vale University Health Board TAKING ORGAN TRANSPLANTATION TO Review of 2015/16 and Action Plan for 2016/17
Contents University Health Board TAKING ORGAN TRANSPLANTATION TO 2020 Review of 2015/16 and Action Plan for 2016/17 CONTENTS 1.0 Executive summary Section 1: Annual Report 2.0 Introduction and background
More information5.2 Main causes of death Brighton & Hove JSNA 2013
Why is this issue important? We need to know how many people are born and die each year and the main causes of their deaths in order to have well-functioning health s. 1 Key outcomes Mortality rate from
More informationCERVICAL SCREENING WALES CERVICAL SCREENING PROGRAMME, WALES: 2001/02
CERVICAL SCREENING WALES INFORMATION TEAM STATISTICAL REPORT CERVICAL SCREENING PROGRAMME, WALES: 2001/02 For more information about this report contact: Helen Beer, Information Analyst / Manager, Screening
More informationNICaN workshop: Colorectal Cancer Follow-up
NICaN workshop: Colorectal Cancer Follow-up The Changing Picture of Colorectal Cancer in Northern Ireland Dr Helen Coleman Lecturer in Cancer Epidemiology & CRUK Population Research Postdoctoral Fellow
More informationINFORMATION TO SUPPORT THE DEVELOPMENT OF THE LINCOLNSHIRE CANCER STRATEGY
INFORMATION TO SUPPORT THE DEVELOPMENT OF THE LINCOLNSHIRE CANCER STRATEGY Refreshed March 2013 Ann Ellis, Health Improvement Principal, NHS Lincolnshire Andrew Smith, Information Analyst, NHS Lincolnshire
More informationWales Cancer Patient Experience. Survey Aneurin Bevan University Health Board. Published January 2014
Wales Cancer Patient Experience Survey 2013 Aneurin Bevan University Health Published January 2014 The Wales Cancer Patient Experience Survey was undertaken by Quality Health on behalf of the Welsh Government
More informationSpecialised Services Policy Position PP151
Specialised Services Policy Position PP151 Complex Devices: Implantable Cardioverter Defibrillators and Cardiac Resynchronisation Therapy for arrhythmias and heart failure January 2019 Version 1.0 Document
More informationData mining Wales: The annual profile for substance misuse
Data mining Wales: The annual profile for substance misuse 2016-17 Annual statistical report on alcohol and drug use on health, social care and education services in Wales through the life course About
More informationTrends in Irish cancer incidence with predictions to 2020
Trends in Irish cancer incidence 1994-22 with predictions to 22 Trends in Irish cancer incidence 1994-22 with projections to 22 National Cancer Registry June 26 1 Acknowledgements. I would like to thank
More informationScreening Division of Public Health Wales NBSW Annual Statistical Report 2017/18
` Date: November 2018 Version: 1 Page: 1 of 29 Date: November 2018 Version: 1 Page: 2 of 29 The report is only available electronically from the screening programme and will be available on the website:
More informationLifestyle and health. Wales and its health boards
and its health boards Lifestyle refers to people s behaviour patterns. Cultural values and beliefs shape these behaviours, which are influenced by personal socio-economic circumstances 1. Harmful behaviours,
More informationWELSH HEALTH CIRCULAR
WHC (2017) Number 23 WELSH HEALTH CIRCULAR Issue Date: 16 June 2017 STATUS: ACTION CATEGORY: POLICY Title: Re-focussing of the Designed to Smile child oral health improvement programme Date of Expiry /
More informationAPPENDIX ONE: ICD CODES
APPENDIX ONE: ICD CODES ICD-10-AM ICD-9-CM Malignant neoplasms C00 C97 140 208, 238.6, 273.3 Lip, oral cavity and pharynx C00 C14 140 149 Digestive organs C15 C26 150 157, 159 Oesophagus 4 C15 150 excluding
More informationTrends in Cancer Survival in NSW 1980 to 1996
Trends in Cancer Survival in NSW 19 to 1996 Xue Q Yu Dianne O Connell Bruce Armstrong Robert Gibberd Cancer Epidemiology Research Unit Cancer Research and Registers Division The Cancer Council NSW August
More informationQuality & Safety Committee
SUMMARY REPORT Quality & Safety Committee Subject Influenza Immunisation Update ABM University Date: 7 December 2016 AGENDA ITEM: 3.1 Prepared, approved and presented by Sara Hayes, Executive Director
More informationCancer in Ireland : Annual Report of the National Cancer Registry
Cancer in Ireland 1-: Annual Report of the National Cancer Registry ABBREVIATIONS % CI % confidence interval APC Annual percentage change ASR Age-standardised rate (European standard population) CNS Central
More informationNational Cancer Intelligence Network short report
National Cancer Intelligence Network short report Produced in partnership with Cancer Research UK Version 2.0 - reissued June 2015 Cancer survival in the UK is lower than in many comparable countries.
More informationPersistent Pain Resources. Educational Slide Set
Persistent Pain Resources Educational Slide Set October 216 This document has been prepared by a multiprofessional collaborative group, with support from the All Wales Prescribing Advisory Group (AWPAG)
More informationALL CANCER (EXCLUDING NMSC)
ALL CANCER (EXCLUDING NMSC) AVERAGE NUMBER OF CASES PER YEAR (2011-2015) AVERAGE NUMBER OF DEATHS PER YEAR (2011-2015) Male Female Both sexes Male Female Both sexes 4,557 4,516 9,073 1 2,196 1,984 4,180
More informationSupplementary Online Content
Supplementary Online Content Henson KE, Brock R, Charnock J, Wickramasinghe B, Will O, Pitman A. Risk of suicide after cancer diagnosis in England. JAMA Psychiatry. Published online November 21, 2018.
More informationNational Standards for Acute Oncology Services
Cancer National Specialist Advisory Group National Standards for Acute Oncology Services June 2016 TABLE OF CONTENTS 1. PURPOSE... 2 2. INTRODUCTION... 2 3. STRATEGIC CONTEXT... 4 4. SCOPE OF ACUTE ONCOLOGY
More informationNATIONAL BOWEL CANCER AUDIT The feasibility of reporting Patient Reported Outcome Measures as part of a national colorectal cancer audit
NATIONAL BOWEL CANCER AUDIT The feasibility of reporting Patient Reported Outcome Measures as part of a national colorectal cancer audit NBOCA: Feasibility Study Date of publication: Thursday 9 th August
More informationwedinos.org WEDINOS Headlines 6,056 Synthetic Cannabinoid Receptor Agonists and the Law 5,058
BULLETIN Issue 10 - Oct - Dec 2016 WEDINOS Quarterly Newsletter Collecting, Testing, Informing wedinos.org WEDINOS Headlines TOTAL number of samples received by WEDINOS October 2013 to December 2016 The
More informationReview of Urgent and Emergency Dental Care in Wales
Review of Urgent and Emergency Dental Care in Wales Dental Public Health Author: Anwen Cope, Specialty Trainee in Dental Public Health Date: 8 th November 2016 Version: 1.0 Publication/ Distribution: NHS
More informationInequalities in cancer survival: Spearhead Primary Care Trusts are appropriate geographic units of analyses
Inequalities in cancer survival: Spearhead Primary Care Trusts are appropriate geographic units of analyses Libby Ellis* 1, Michel P Coleman London School of Hygiene and Tropical Medicine *Corresponding
More informationIn your area: BMA Cymru Wales
In your area: BMA Cymru Wales Cymru Wales Supporting you locally 2017-18 British Medical Association bma.org.uk/wales Our mission: We look after doctors so they can look after you. Our values: Expert We
More informationLower your risk of stroke. Community pharmacy public health campaign report
Lower your risk of stroke. Community pharmacy public health campaign report Author: Andrew Evans, Principal Pharmacist in Pharmaceutical Public Health Date: 16 August 2013 Version: 1 Publication/ Distribution:
More informationALL CANCER (EXCLUDING NMSC)
ALL CANCER (EXCLUDING NMSC) AVERAGE NUMBER OF CASES PER YEAR (2012-2016) AVERAGE NUMBER OF DEATHS PER YEAR (2012-2016) Male Female Both sexes Male Female Both sexes 4,607 4,632 9,240 1 2,238 2,036 4,274
More informationSuggested Change PiMS Domai PiMS Values Mapping. 1 X-Ray 204 BIOC Biochemistry 199
Betsi Cadwaladr University Local Health Board Ysbyty Glan Clwyd Betsi Cadwaladr University Local Health Board Ysbyty Gwynedd Local Code Description Nat Code Suggested Change PiMS Domai PiMS Values Mapping
More informationWALES BOWEL CANCER SCREENING PILOT: EVALUATION REPORT PROJECT DATES: FEBRUARY TO APRIL 2015
WALES BOWEL CANCER SCREENING PILOT: EVALUATION REPORT PROJECT DATES: FEBRUARY TO APRIL 2015 Published August 2016 ACKNOWLEDGEMENTS This pilot was developed in partnership with Public Health Wales, and
More informationCancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group
Cancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group Introduction There are more than 200 different types of cancer. It is also referred to as malignancies,
More informationPreventing relapse in schizophrenia: a real priority or only a tick-box exercise? John Donoghue Liverpool
Preventing relapse in schizophrenia: a real priority or only a tick-box exercise? John Donoghue Liverpool L imagination est plus important que le savoir Albert Einstein Copyright John Donoghue 2013 These
More informationWEDINOS Headlines 6,452. wedinos.org 5,806 BULLETIN. Samples. received. Samples. received. Samples. analysed. Samples. rejected
BULLETIN Issue 11 - Jan - Mar 2017 WEDINOS Quarterly Newsletter Collecting, Testing, Informing wedinos.org WEDINOS Headlines TOTAL number of samples received by WEDINOS October 2013 to March 2017 The WEDINOS
More informationCancer in Ireland : Annual Report of the National Cancer Registry
Cancer in Ireland 1994-213: Annual Report of the National Cancer Registry 215 Page 3 ABBREVIATIONS 95% CI 95% confidence interval APC Annual percentage change ASR Age-standardised rate (European standard
More informationThe Cervical Screening Programme in Wales
The Cervical Screening Programme in Wales Bryan G Rose Cervical\Screening Wales CSSW presentation 12 th March 2011 Cervical Screening In Wales What s occurin Cervical Screening In Wales WAZ UUUUP! Disclaimer
More informationMacmillan-NICR Partnership: GP Federation Cancer Profiles (with Prevalence )
Macmillan-NICR Partnership: GP Federation Cancer Profiles 2011-2015 (with Prevalence 1993-2015) 1 C a n c e r S t a t i s t i c s b y G P F e d e r a t i o n a r e a : 2 0 1 1-2015 Table of Contents Introduction...
More informationCancer survival in Bhopal, India,
Chapter 13 Cancer survival in Bhopal, India, 1991 1995 Dikshit R, Kanhere S and Surange S Abstract The Bhopal population-based cancer registry was established in 1986 under the national cancer registry
More informationCommunity pharmacy diabetes risk health promotion campaign
Community pharmacy diabetes risk health promotion campaign Author: Nuala Brennan, Consultant in Pharmaceutical Public Health Date: 24 August 2011 Version: 2 Publication/ Distribution: Distribution to:
More informationImproving Oral Health Together
Improving Oral Health Together An Oral Health and Dental Service Improvement Plan for Abertawe Bro Morgannwg University Health Board Reducing Inn Oral Reduced inequities A five year vision Contents: Foreword
More informationNational Update: Living With and Beyond Cancer Implementing Strategic Priority 4 of the National Cancer Taskforce
National Update: Living With and Beyond Cancer Implementing Strategic Priority 4 of the National Cancer Taskforce Duleep Allirajah Head of Policy, Macmillan Cancer Support Total Prevalence - now Total
More informationNational Prescribing Indicators Annual Primary Care Prescribing Report
National Prescribing Indicators 214 215 Annual Primary Care Prescribing Report This report has been prepared by the Welsh Analytical Prescribing Support Unit (WAPSU), part of the All Wales Therapeutics
More informationCancer in the Northern Territory :
Cancer in the Northern Territory 1991 21: Incidence, mortality and survival Xiaohua Zhang John Condon Karen Dempsey Lindy Garling Acknowledgements The authors are grateful to the many people, who have
More informationFreedom of Information Act Request Rookwood Hospital
Freedom of Information Act Request Rookwood Hospital With regard to the planned move of the spinal injuries unit at Rookwood to University Hospital Llandough please provide the following information: Question
More informationHCV ACTION CARDIFF HEPATITIS C GOOD PRACTICE ROADSHOW, 8TH DECEMBER 2017 SUMMARY REPORT
HCV ACTION CARDIFF HEPATITIS C GOOD PRACTICE ROADSHOW, 8TH DECEMBER 2017 SUMMARY REPORT Introduction On 8 th December, HCV Action and Public Health Wales (PHW) staged the third and final hepatitis C good
More informationMarch 2012: Review September 2012
10. Cancer This section of the JSNA explores the incidence, prevalence, mortality and survival rates of cancer, to inform target setting and commissioning. Approximately 1200 Trafford residents are diagnosed
More informationCancer projections National Cancer Registry
Cancer projections 25-235 National Cancer Registry Published by the National Cancer Registry 28 Building 68, Cork Airport Business Park, Kinsale Road, Cork, Ireland Telephone 21-431814 Email Web site info@ncri.ie
More informationCANCER FACTS & FIGURES For African Americans
CANCER FACTS & FIGURES For African Americans Pennsylvania, 2006 Pennsylvania Cancer Registry Bureau of Health Statistics and Research Contents Data Hightlights...1 Pennsylvania and U.S. Comparison...5
More information